A ranar 9 ga Fabrairu, 2026, gidan yanar gizon hukuma na Cibiyar Kimanta Magunguna (CDE) ta Hukumar Kayayyakin Lafiya ta Ƙasa (NMPA) ya sanar da cewa ZL-1310 don allura, wani sabon maganin rigakafi na DLL3 mai niyya ga ƙwayoyin cuta (ADC), an shirya ba shi suna na Breakthrough Therapy.
A matsayinka na memba na Ƙungiyar Likitoci ta Asibitin Ciwon daji ta Jami'ar Peking da kuma wani asibiti na musamman na ciwon daji na zamani na Beijing, Sashen Ƙasa da Ƙasa na Asibitin Kanjamau na Beijing South Region yana amfani da wani dandamali mai ƙarfi na bincike da magani don haɗa irin waɗannan hanyoyin magancewa a duniya cikin sauri cikin shirye-shiryen maganin marasa lafiya na ƙasashen duniya. Idan kai ko ƙaunataccenka yana fuskantar ƙalubalen maganin ciwon daji na ƙananan ƙwayoyin cuta ko na baya, da fatan za a karanta bayanan da ke ƙasa a hankali kuma a tuntuɓe mu nan da nan.
Tuntuɓi Sashen Ƙasa da Ƙasa na Asibitin Oncology na Yankin Kudu na Beijing yanzu:
- Waya: 400-880-3716
- WeChat ID: 17801183037
- Email ①: 100085_010@163.com
- Email ②: myimmnet@163.com
**Bayanan da ke da Tauri: Har zuwa kashi 86% na Inganci ga Marasa Lafiya da ke fama da Ciwon Kwakwalwa**
A taron shekara-shekara na Ƙungiyar Kula da Cututtukan Asibiti ta Amurka (ASCO) na shekarar 2025, an gabatar da bayanan nazarin asibiti na mataki na 1a/1b na duniya don ZL-1310.
Ga marasa lafiya da aka yi wa magani a baya (maganin layi na biyu):
- Adadin martanin da ba a tabbatar da shi ba (uORR) ya kai kashi 67%, tare da ƙimar rage cututtuka (DCR) na kashi 97%.
- A cikin rukunin maganin kwayoyin halitta mafi kyau (1.6 mg/kg): Matsakaicin amsawar da aka yi niyya (ORR) ya karu zuwa 79%, tare da ƙimar rage cututtuka (DCR) na 100%.
- Wannan yana nufin: Kusan dukkan marasa lafiya 10 da suka karɓi wannan maganin sun sami nasarar rage girman ciwon, kuma kusan marasa lafiya 8 sun fuskanci raguwar ciwon.
Ga marasa lafiya mafi ƙalubale da suka kamu da cutar kwakwalwa:
- Marasa lafiya da suka kamu da cutar kwakwalwa ta asali: Matsakaicin amsawar da aka yi niyya (ORR) shine kashi 68%.
- Marasa lafiya waɗanda ba su taɓa yin amfani da na'urar radiation ta kwakwalwa ba: Matsakaicin amsawar da aka yi da gangan (ORR) ya kai kashi 86%!
Wannan bayanai suna da matuƙar muhimmanci. Magungunan chemotherapy na gargajiya suna ƙoƙarin shiga shingen jini da kwakwalwa, duk da haka ZL-1310 yana nuna ƙarfin aikin hana ƙari a cikin kwakwalwa. Ga marasa lafiya na ƙasashen duniya da ke damuwa game da illolin radiation na kwakwalwa gaba ɗaya, wannan yana wakiltar babban bege na "guje wa radiation na kwakwalwa."
**Bayanin Tsaro:** A cikin rukunin allurai sama da 2.0 mg/kg, yawan aukuwar abubuwan da suka shafi magani (TRAEs) na aji 3 ko sama da haka ya kai kashi 6% kacal, ba tare da an bayar da rahoton wani lamari da ya shafi magani ko kuma dakatar da magani ba.
—
**III. Me Yasa Zabi Sashen Ƙasa da Ƙasa na Asibitin Cutar Kanjamau na Yankin Kudu na Beijing?**
Ga marasa lafiya na ƙasashen duniya, samun sabbin hanyoyin magance matsalolin ba wai kawai game da "ko maganin yana samuwa ba," har ma da tsari mai tsari wanda ya ƙunshi "wanda zai iya amfani da shi, yadda ake amfani da shi, da kuma wanda zai sarrafa illolin da ke tattare da shi."
Sashen Ƙasa da Ƙasa na Asibitin Oncology na Yankin Kudu na Beijing yana ba da kimantawa mai zuwa da kuma cikakken kulawa don jiyya na zamani kamar ZL-1310 ga marasa lafiya da suka cancanta. Ko kai daga Kudu maso Gabashin Asiya ne, Gabas ta Tsakiya, Turai, ko Amurka, muna da tsarin kula da lafiya na duniya wanda aka kafa sosai.
Muna bayar da ayyuka masu cikakken bayani tun daga shawarwarin da aka bayar kafin a kai asibiti, fassarar harsuna da yawa, wasiƙun bizar likita, zuwa bin diddigin gyaran hali. Bin ƙa'idar "likita ɗaya, majiyyaci ɗaya, ɗaki ɗaya" yana tabbatar da cewa an girmama sirrinka da mutuncinka, har ma a ƙasar waje.
A halin yanzu, Hukumar Kula da Lafiya ta Amurka (FDA) ta ba wa ZL-1310 izinin zama Magungunan Marayu da kuma sanya shi cikin jerin magungunan da za a iya amfani da su cikin sauri. Shirin da aka tsara na sanya shi cikin jerin magungunan da za a iya amfani da su a kasar Sin zai hanzarta samun damarsa a kasar Sin sosai.
Kada ku bari shingen harshe, gibin bayanai, ko hanyoyin da ba su da tsauri su hana ku samun magunguna na zamani. Sashen Kula da Cututtukan Cututtuka na Yankin Kudu na Beijing ya kafa wata hanya mai kyau ga marasa lafiya na ƙasashen duniya.
Ɗauki wayar ko ku tuntube mu ta WeChat ko imel don raba mana da halin da kuke ciki. Masu ba da shawara kan harkokin lafiya za su ba da kimantawa ta farko cikin awanni 24.
- Waya (shawarwari na awanni 24): 400-880-3716
- WeChat (sadarwar nan take): 17801183037 (yana goyan bayan Turanci da Sinanci)
- Imel (don bayanan likita):
- 100085_010@163.com
- myimmnet@163.com
Lokacin Saƙo: Fabrairu-12-2026